SCHEMBL528434

SCHEMBL528434

CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)OC(CO)COC(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 5/20 0.82
PRKCE Q02156 2/20 0.82
PRKCQ Q04759 2/20 0.82
PRKCD Q05655 2/20 0.82
DGKA P23743 1/20 0.72
ENPP2 Q13822 2/20 0.63
RECQL P46063 1/20 0.62
BLM P54132 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
LPAR3 Q9UBY5 1/20 0.62
FAAH O00519 3/20 0.61
LPAR1 Q92633 2/20 0.59
ALDH1A1 P00352 2/20 0.59
LMNA P02545 1/20 0.59
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
CNR1 P21554 1/20 0.58
CNR2 P34972 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15011158 0.96 PRKCA (0.76) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL6237326 0.94 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL1924789 0.91 PRKCA (0.79) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL237351 0.91 PRKCA (0.79) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL15011314 0.91 PRKCA (0.79) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL528141 0.91 PRKCA (0.79) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL7162946 0.90 PRKCA (0.80) PRKCAPRKCEPRKCQPRKCDDGKA
Diolein SCHEMBL160985 0.90 PRKCA (1.00) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL8384463 0.90 PRKCA (1.00) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL21436106 0.90 PRKCA (1.00) PRKCAPRKCEPRKCQPRKCDDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011130385-A1 BIOMARKERS FOR HEPATOCELLULAR CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC 2011-10-20 WO claimed
EP-2972326-B1 A NONINVASIVE METHOD FOR MEASURING METABOLITES FOR SKIN HEALTH PROCTER & GAMBLE (US) 2020-01-08 EP disclosed
EP-2432462-A2 ENDOXIFEN METHODS AND COMPOSITIONS IN THE TREATMENT OF MAMMALIAN DISEASES Jina Pharmaceuticals Inc. (US) 2012-03-28 EP disclosed
WO-2011130385-A1 BIOMARKERS FOR HEPATOCELLULAR CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC 2011-10-20 WO disclosed
US-5985663-A AN ANTISENSE COMPOUND 8 TO 30 NUCLEOBASES IN LENGTH TARGETED TO A 5' UNTRANSLATED REGION OR 3' UNTRANSLATED REGION OF A NUCLEIC ACID ENCODING HUMAN INTERLEUKIN-15 ISIS PHARMACEUTICALS INC. (US) 1999-11-16 US disclosed